Girard Partners Ltd. Amgen Inc Transaction History

Girard Partners Ltd.

$1.06 Billion
Q2 2024

A detailed history of Girard Partners Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Girard Partners Ltd. holds 18,277 shares of AMGN stock, worth $5.3 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

18,277

Previous 18,506 1.24%

Holding current value

$5.3 Million

Previous $5.26 Million 8.53%

% of portfolio

0.54%

Previous 0.5%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $60,169 - $73,121	-229 Reduced 1.24%	18,277 $5.71 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $367,545 - $443,673	-1,367 Reduced 6.88%	18,506 $5.26 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $216,322 - $244,037	-846 Reduced 4.08%	19,873 $5.72 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $431,177 - $535,319	-1,972 Reduced 8.69%	20,719 $5.57 Million
Q2 2023 Aug 15, 2023	SELL	$214.27 - $253.37 $5.06 Million - $5.99 Million	-23,625 Reduced 51.01%	22,691 $5.04 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $1.35 Million - $1.65 Million	5,986 Added 14.84%	46,316 $11.2 Million
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $112,911 - $143,467	-493 Reduced 1.21%	40,330 $0
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $915,347 - $1.03 Million	-4,078 Reduced 9.08%	40,823 $9.2 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $732,734 - $815,406	-3,176 Reduced 6.61%	44,901 $10.9 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $796,607 - $881,256	3,633 Added 8.17%	48,077 $11.6 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $395,373 - $452,468	-1,988 Reduced 4.28%	44,444 $10 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $7.76 Million - $9.09 Million	36,559 Added 370.29%	46,432 $9.87 Million
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $7.47 Million - $8.75 Million	-35,182 Reduced 78.09%	9,873 $9.87 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $513,876 - $570,108	-2,200 Reduced 4.66%	45,055 $11 Million
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $211,702 - $246,704	954 Added 2.06%	47,255 $11.8 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $342,313 - $407,633	-1,582 Reduced 3.3%	46,301 $10.6 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $159,562 - $177,446	680 Added 1.44%	47,883 $12.2 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $344,189 - $422,367	-1,740 Reduced 3.56%	47,203 $11.1 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $64.5 Million - $85.6 Million	-354,123 Reduced 87.86%	48,943 $9.92 Million
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $64.7 Million - $85.8 Million	355,040 Added 739.27%	403,066 $10.3 Million
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $84,009 - $107,980	444 Added 0.93%	48,026 $11.6 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $87,055 - $104,310	-500 Reduced 1.04%	47,582 $9.21 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $874,674 - $1.03 Million	5,247 Added 12.25%	48,082 $8.86 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $175,443 - $197,763	970 Added 2.32%	42,835 $8.14 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $407,465 - $475,643	-2,284 Reduced 5.17%	41,865 $8.15 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $162,499 - $183,196	-877 Reduced 1.95%	44,149 $9.15 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $7.48 Million - $8.4 Million	45,026 New	45,026 $8.31 Million
Q1 2018 Apr 18, 2018	SELL	$169.43 - $198.0 $7.29 Million - $8.52 Million	-43,026 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $369,650 - $413,012	2,190 Added 5.36%	43,026 $7.48 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $115,764 - $132,172	692 Added 1.72%	40,836 $7.61 Million
Q2 2017 Aug 08, 2017	BUY	N/A	40,144	40,144 $6.91 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Account

Girard Partners Ltd. Amgen Inc Transaction History